ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 152 filers reported holding ARCUS BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 3.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $987,951 | -11.7% | 54,164 | +0.1% | 0.00% | 0.0% |
| Q4 2022 | $1,118,767 | +322.2% | 54,099 | +543.8% | 0.00% | +300.0% |
| Q1 2022 | $265,000 | -65.7% | 8,403 | -56.0% | 0.00% | -50.0% |
| Q4 2021 | $773,000 | +1.0% | 19,103 | -13.0% | 0.00% | -33.3% |
| Q3 2021 | $765,000 | -8.3% | 21,952 | -27.7% | 0.00% | 0.0% |
| Q2 2021 | $834,000 | -18.6% | 30,382 | -16.7% | 0.00% | -40.0% |
| Q1 2021 | $1,024,000 | +163.2% | 36,476 | +143.4% | 0.01% | +150.0% |
| Q4 2020 | $389,000 | – | 14,988 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |